The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP.
Open accessAbstract
Substitution of asparagine for serine at position 17 decreased the affinity of rasH p21 for GTP 20- to 40-fold without significantly affecting its affinity for GDP. Transfection of NIH 3T3 cells with a mammalian expression vector containing the Asn-17 rasH gene and a Neor gene under the control of the same promoter yielded only a small fraction of the expected number of G418-resistant colonies, indicating that expression of Asn-17 p21 inhibited cell proliferation. The inhibitory effect of Asn-17 p21 required its localization to the plasma membrane and was reversed by coexpression of an activated ras gene, indicating that the mutant p21 blocked the endogenous ras function required for NIH 3T3 cell proliferation. NIH 3T3 cells transformed by v-mos and v-raf, but not v-src, were resistant to inhibition by Asn-17 p21, indicating that the requirement for normal ras function can be bypassed by these cytoplasmic oncogenes. The Asn-17 mutant represents a novel reagent for the study of ras function by virtue of its ability to inhibit cellular ras activity in vivo. Since this phenotype is likely associated with the preferential affinity of the mutant protein for GDP, analogous mutations might also yield inhibitors of other proteins whose activities are regulated by guanine nucleotide binding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
G PROTEINS: TRANSDUCERS OF RECEPTOR-GENERATED SIGNALS
Gilman, A. G. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003151 · Cited by 6,381
Barbacid, M. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004023 · Cited by 3,885
A Cytoplasmic Protein Stimulates Normal N- ras p21 GTPase, But Does Not Affect Oncogenic Mutants
Trahey, M., & McCormick, F. (1987) · Science · doi:10.1126/science.2821624 · Cited by 1,211
In yeast, RAS proteins are controlling elements of adenylate cyclase
Toda, T., Uno, I., Ishikawa, T., Powers, S., Kataoka, T., Broek, D., Cameron, S., Broach, J., Matsumoto, K., & Wigler, M. (1985) · Cell · doi:10.1016/0092-8674(85)90305-8 · Cited by 1,108
Construction and applications of a highly transmissible murine retrovirus shuttle vector
Cepko, C. L., Roberts, B. E., & Mulligan, R. C. (1984) · Cell · doi:10.1016/0092-8674(84)90440-9 · Cited by 992
Preiss, J., Loomis, C. R., Bishop, W. R., Stein, R., Niedel, J. E., & Bell, R. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84420-4 · Cited by 981
Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells
Mulcahy, L. S., Smith, M. R., & Stacey, D. W. (1985) · Nature · doi:10.1038/313241a0 · Cited by 878
Induction of Membrane Ruffling and Fluid-Phase Pinocytosis in Quiescent Fibroblasts by ras Proteins
Bar-Sagi, D., & Feramisco, J. R. (1986) · Science · doi:10.1126/science.3090687 · Cited by 734
Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation
Bar-Sagi, D., & Feramisco, J. R. (1985) · Cell · doi:10.1016/0092-8674(85)90280-6 · Cited by 725
Cited by
Items 101–129 of 129
Mayerhofer, M., Valent, P., Sperr, W. R., Griffin, J. D., & Sillaber, C. (2002) · Blood · doi:10.1182/blood-2002-01-0109 · Cited by 273
Functional Specificity of Ras Isoforms: So Similar but So Different
Castellano, E., & Santos, E. (2011) · Genes & Cancer · doi:10.1177/1947601911408081 · Cited by 273
The Son of sevenless Gene Product: a Putative Activator of Ras
Bonfini, L., Karlovich, C. A., Dasgupta, C., & Banerjee, U. (1992) · Science · doi:10.1126/science.1736363 · Cited by 272
Involvement of p21ras distinguishes positive and negative selection in thymocytes.
Swan, K. A., Alberola-Ila, J., Gross, J. A., Appleby, M. W., Forbush, K. A., Thomas, J. F., & Perlmutter, R. M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07001.x · Cited by 272
Structure–function analysis of the tobacco mosaic virus resistance gene N
Dinesh-Kumar, S. P., Tham, W.-H., & Baker, B. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14789 · Cited by 270
Caldwell, P. E., Walkiewicz, M., & Stern, M. (2005) · Current Biology · doi:10.1016/j.cub.2005.09.011 · Cited by 267
Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras?
Cox, A. D., & Der, C. J. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00011-5 · Cited by 266
Involvement of Ral GTPase in v-Src-induced phospholipase D activation
Jiang, H., Luo, J.-Q., Urano, T., Frankel, P., Lu, Z., Foster, D. A., & Feig, L. A. (1995) · Nature · doi:10.1038/378409a0 · Cited by 265
Self-citationYasuda, R., Harvey, C. D., Zhong, H., Sobczyk, A., van Aelst, L., & Svoboda, K. (2006) · Nature Neuroscience · doi:10.1038/nn1635 · Cited by 261
The native structure of the activated Raf protein kinase is a membrane-bound multi-subunit complex.
Wartmann, M., & Davis, R. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37431-8 · Cited by 261
Notch Inhibition of E47 Supports the Existence of a Novel Signaling Pathway
Ordentlich, P., Lin, A., Shen, C.-P., Blaumueller, C., Matsuno, K., Artavanis-Tsakonas, S., & Kadesch, T. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.2230 · Cited by 254
Sawyers, C. L., McLaughlin, J., & Witte, O. N. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.307 · Cited by 253
The small GTP-binding protein rab6 functions in intra-Golgi transport.
Martinez, O., Schmidt, A., Salaméro, J., Hoflack, B., Roa, M., & Goud, B. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.6.1575 · Cited by 253
Aichberger, K. J., Mayerhofer, M., Krauth, M.-T., Skvara, H., Florian, S., Sonneck, K., Akgul, C., Derdak, S., Pickl, W. F., Wacheck, V., et al. (2005) · Blood · doi:10.1182/blood-2004-02-0749 · Cited by 253
Guardavaccaro, D., Corrente, G., Covone, F., Micheli, L., D'Agnano, I., Starace, G., Caruso, M., & Tirone, F. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1797-1815.2000 · Cited by 230
c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor
Behre, G., Whitmarsh, A. J., Coghlan, M. P., Hoang, T., Carpenter, C. L., Zhang, D.-E., Davis, R. J., & Tenen, D. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4939 · Cited by 180
The Ras-related Protein Rheb Is Farnesylated and Antagonizes Ras Signaling and Transformation
Clark, G. J., Kinch, M. S., Rogers-Graham, K., Sebti, S. M., Hamilton, A. D., & Der, C. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10608 · Cited by 177
Büscher, D., Hipskind, R. A., Krautwald, S., Reimann, T., & Baccarini, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.466 · Cited by 176
“To determine whether the CSF-1 signal actually required an active Ras upstream of Raf, a dominant inhibitory ras mutant and c-Ha-ras (15, 25, 26) were inducibly expressed in BAC-1.”
BackgroundMethodBabbey, C. M., Ahktar, N., Wang, E., Chen, C. C.-H., Grant, B. D., & Dunn, K. W. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-08-0799 · Cited by 164
Shen, K., Choe, A., & Sabatini, D. M. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.026 · Cited by 101
“…to RagA and RagC (Supplementary Figure 1A), and in heterodimers in which RagA or RagC had a mutation that mimics the Ras(S17N) mutant that does not bind GTP (RagA T21N; RagC S75N) (Feig and Cooper, 1988; Sancak et al., 2008), GTP bound only to the wildtype subunit (Supplementary Figures 1B and 1C).”
Kelly, P. A., & Rahmani, Z. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-12-1085 · Cited by 86
Dick, F. A. (2007) · Cell Division · doi:10.1186/1747-1028-2-26 · Cited by 79
Activation of c-Raf Kinase by Ultraviolet Light
Hoyos, B., Imam, A., Korichneva, I., Levi, E., Chua, R., & Hammerling, U. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110750200 · Cited by 55
Ehrhardt, G. R. A., Leslie, K. B., Lee, F., Wieler, J. S., & Schrader, J. W. (1999) · Blood · doi:10.1182/blood.v94.7.2433.419k31_2433_2444 · Cited by 54
Matsuzaki, T., Aisaki, K.-I., Yamamura, Y., Noda, M., & Ikawa, Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203461 · Cited by 40
Nicolaou, F., Teodoridis, J. M., Park, H., Georgakis, A., Farokhzad, O. C., Böttinger, E. P., Da Silva, N., Rousselot, P., Chomienne, C., Ferenczi, K., et al. (2003) · Blood · doi:10.1182/blood-2002-01-0324 · Cited by 39
Peeper, D. S., & Bernards, R. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00319-0 · Cited by 36
Selective Activation of Ha-rasval12Oncogene Increases Susceptibility of NIH/3T3 Cells to TNF-α
Chang, M.-Y., Won, S.-J., Yang, B.-C., Jan, M.-S., & Liu, H.-S. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4436 · Cited by 20
Mutant and wild-type Ras: co-conspirators in cancer
Hayes, T. K., & Der, C. J. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0521 · Cited by 13
Metadata
- Authors
- Feig, L. A., & Cooper, G. M.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1988-08
- Volume
- 8
- Issue
- 8
- Pages
- 3235-3243
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2158608327
- Cited by
- 798
- References
- 49
- FWCI
- 5.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.